Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOA | P21397 | 3/20 | 0.38 |
| ▸ | MAOB | P27338 | 1/20 | 0.38 |
| ▸ | TSHR | P16473 | 2/20 | 0.36 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.36 |
| ▸ | HTT | P42858 | 1/20 | 0.36 |
| ▸ | HTR6 | P50406 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11292287 | 0.70 | MAOA (0.44) | MAOAMAOBTSHRMAPK1HTT | |
| SCHEMBL11296073 | 0.68 | MAOA (0.49) | MAOAMAOBTSHRMAPK1HTT | |
| SCHEMBL11283989 | 0.68 | MAOA (0.42) | MAOAMAOBTSHRMAPK1HTT | |
| SCHEMBL31035393 | 0.68 | ALDH1A1 (0.33) | ALDH1A1SMN1; SMN2 | |
| SCHEMBL31285230 | 0.68 | MAPK14 (0.36) | — | |
| SCHEMBL31217576 | 0.66 | PIM1 (0.48) | MAOAMAOBTSHRHTR6ALDH1A1 | |
| SCHEMBL11408384 | 0.66 | HSD17B10 (0.47) | MAOAMAPK1ALDH1A1SMN1; SMN2HSD17B10 | |
| SCHEMBL31217552 | 0.66 | TSHR (0.41) | MAOAMAOBTSHRMAPK1HTT | |
| SCHEMBL31284348 | 0.65 | CSNK2A2 (0.36) | — | |
| SCHEMBL31285059 | 0.65 | SIRT2 (0.40) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4731626-A1 | PI3K INHIBITORS AND USE THEREOF | Regor Pharmaceuticals, Inc. (US) | 2026-04-29 | — | — | EP | disclosed |
| WO-2024260464-A1 | PI3K INHIBITORS AND USE THEREOF | REGOR PHARMACEUTICALS, INC. (US) | 2024-12-26 | — | — | WO | disclosed |